Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120946933 | 12094693 | 3 | F | 20160209 | 20160622 | 20160219 | 20160701 | EXP | US-ELI_LILLY_AND_COMPANY-US201602003967 | ELI LILLY AND CO | 27.92 | YR | M | Y | 0.00000 | 20160630 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120946933 | 12094693 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Unknown | 2 DF, QD | C459623A | 21368 | 2 | DF | TABLET | QD | |||||
| 120946933 | 12094693 | 2 | SS | ADCIRCA | TADALAFIL | 1 | Unknown | 20 MG, BID | C464095A | 21368 | 20 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120946933 | 12094693 | 1 | Cor pulmonale chronic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120946933 | 12094693 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120946933 | 12094693 | Ascites | |
| 120946933 | 12094693 | Asthenia | |
| 120946933 | 12094693 | Chills | |
| 120946933 | 12094693 | Oedema peripheral | |
| 120946933 | 12094693 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120946933 | 12094693 | 1 | 201503 | 0 |